Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P43026 (
lipopolysaccharide
)
62,215
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Muscle denervation resulting from injury, disease or aging results in impaired motor function. Restoring neuromuscular communication requires axonal regrowth and endplate reinnervation. Muscle activity inhibits the reinnervation of denervated muscle. The mechanism by which muscle activity regulates muscle reinnervation is poorly understood.
Dach2
and Hdac9 are activity-regulated transcriptional co-repressors that are highly expressed in innervated muscle and suppressed following muscle denervation.
Dach2
and Hdac9 control the expression of endplate-associated genes such as those encoding nicotinic acetylcholine receptors (nAChRs). Here we tested the idea that
Dach2
and Hdac9 mediate the effects of muscle activity on muscle reinnervation.
Dach2
and Hdac9 were found to act in a collaborative fashion to inhibit reinnervation of denervated mouse skeletal muscle and appear to act, at least in part, by inhibiting denervation-dependent induction of Myog and
Gdf5
gene expression. Although
Dach2
and Hdac9 inhibit Myog and
Gdf5
mRNA expression, Myog does not regulate
Gdf5
transcription. Thus, Myog and
Gdf5
appear to stimulate muscle reinnervation through parallel pathways. These studies suggest that manipulating the
Dach2
-Hdac9 signaling system, and
Gdf5
in particular, might be a good approach for enhancing motor function in instances where neuromuscular communication has been disrupted.
...
PMID:Dach2-Hdac9 signaling regulates reinnervation of muscle endplates. 2648 11